CSL

CSL Driven by our promise to help patients lead full lives. Social Guidelines: https://bit.ly/3Bs17Ra

27/05/2026

What does a day at CSL look like?

For our teams, it’s a balance of collaboration, focus and purpose-driven work – each moment contributing to something bigger.

Take a look inside a typical day and see how our people are making an impact.

Explore careers: csl.com/careers

26/05/2026

Lisa Butler, President & CEO of the GBS-CIDP Foundation International, sat down with Emma Hatcher, Director of U.S. Patient Advocacy at CSL, to explain Chronic Inflammatory Demyelinating Polyneuropathy ( ).

CIDP, an autoimmune disease affecting the peripheral nervous system, causes extreme weakness and profound fatigue. These unpredictable symptoms can disrupt daily life, turning routine activities into significant challenges for those living with the condition.

Learn more: https://bit.ly/4f0Q070

Every safe, effective therapy starts with clinical trials—and they wouldn’t happen without the people who step forward t...
20/05/2026

Every safe, effective therapy starts with clinical trials—and they wouldn’t happen without the people who step forward to participate, or the clinical research professionals who bring these studies to life.

Thank you to the people who participate in clinical research studies to advance new medicines and everyone working to turn scientific discovery into real-world impact.

The experience of hereditary angioedema (HAE) reminds us that progress in rare disease is about more than science alone....
18/05/2026

The experience of hereditary angioedema (HAE) reminds us that progress in rare disease is about more than science alone.

Professor Konrad Bork, a pioneer in HAE who has shaped the field for more than four decades, shared his perspective on the evolution of HAE care, the remaining challenges and his experience of HAE.

With HAE Day taking place in May, we want to recognize the role of the healthcare community in helping improve understanding of this rare disease, support earlier recognition, and drive progress in care.

Read the full interview here: https://www.csl.com/we-are-csl/vita-original-stories/2026/an-hae-pioneer-reflects-on-the-evolution-of-care?utm_source=Social+Media&utm_medium=Facebook&utm_campaign=HAE

More than 33,000 patients participated in our clinical trials in fiscal year 2025, helping CSL drive innovation and tran...
18/05/2026

More than 33,000 patients participated in our clinical trials in fiscal year 2025, helping CSL drive innovation and transform lives.

Every breakthrough starts with passionate people working behind the scenes to make a difference.

Be part of a team advancing breakthroughs that improve health worldwide. Discover opportunities: csl.com/careers

17/05/2026

Feeling supported makes a difference.

At CSL, we offer wellness days and resources that give our employees time to reset and recharge – so they can bring their best to work and beyond.

Because supporting health starts from within.

Explore careers: csl.com/careers

The experience of hereditary angioedema (HAE) can be unpredictable, disruptive and difficult for others to fully see. Me...
16/05/2026

The experience of hereditary angioedema (HAE) can be unpredictable, disruptive and difficult for others to fully see.

Melissa shared her HAE story, and the burden of unpredictable, painful and potentially life-threatening swelling attacks.

With HAE Day taking place in May, we’re recognizing the lived reality of HAE and the importance of greater awareness, understanding and support for the community.

To provide further perspective, Professor Konrad Bork, a pioneer in HAE research, shares his expert insights in an interview exploring the importance of how awareness, experience, and collaboration continue to drive progress in rare disease care: https://www.csl.com/we-are-csl/vita-original-stories/2026/an-hae-pioneer-reflects-on-the-evolution-of-care?utm_source=Social+Media&utm_medium=Facebook&utm_campaign=HAE_Melissa

15/05/2026

Watch to hear Jack’s story (in his own words) and learn what it really means to live with HAE.

Click the link to learn more about Jack’s story: csl.com/impact

The experience of hereditary angioedema (HAE) can be shaped by years of unanswered questions. Makiko sadly lost her husb...
13/05/2026

The experience of hereditary angioedema (HAE) can be shaped by years of unanswered questions.

Makiko sadly lost her husband to HAE before he ever received a diagnosis. Her daughter has since been diagnosed with the condition and Makiko now advocates for improved awareness of HAE as Director of the patient group, HAE Japan. She says, “Just knowing ‘I’m not the only one’ helps people face forward a little more.”

With HAE Day taking place in May, we want to recognize the strength of the HAE community, a community CSL has been proud to support for over 45 years. By raising awareness of HAE, we can help more people recognize the signs, seek support earlier, and move closer to the clarity every family deserves.

Find out more about Makiko’s story here: https://www.csl.com/we-are-csl/vita-original-stories/2026/what-loss-has-taught-me-about-sharing?utm_source=Social+Media&utm_medium=Facebook&utm_campaign=HAE

07/05/2026

Your work at CSL isn’t just a job — it’s a mission.

Every innovation, every breakthrough and every effort helps deliver lifesaving and life-changing medicines to patients worldwide. From pioneering plasma technologies to advancing global health initiatives, our teams are shaping the future of medicine.

Join us and be part of a company where your talent powers progress and transforms lives.

Explore careers: csl.com/careers

Address

645 Elizabeth Street
Melbourne, VIC
3000

Telephone

+61393891911

Website

Alerts

Be the first to know and let us send you an email when CSL posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to CSL:

Shortcuts

Share

Category